IP vs SPRY
International Paper (IP) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the IP and SPRY stock pages for the full models.
Not investment advice.